Why the study?
Given recent advances in epicardial lead subtypes, investigating their long-term function and comparing the performance of bipolar steroid-eluting versus unipolar non-steroid-eluting epicardial pacemakers is essential.
Do bipolar steroid-eluting epicardial leads improve lead survival compared to unipolar non-steroid-eluting leads in patients requiring epicardial pacemakers?
Do bipolar steroid-eluting epicardial leads improve lead survival compared to unipolar non-steroid-eluting leads in patients requiring epicardial pacemakers?
Bipolar steroid-eluting epicardial leads demonstrate significantly better 48-month survival and more stable pacing thresholds compared to unipolar non-steroid-eluting leads.
No takes yet. Share an insight, caveat, or question.
May support bipolar steroid-eluting leads in epicardial pacing; leaves open need for randomized confirmation.
Fazelifar et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: